Gabapentin and Cardiogenic shock - a phase IV clinical study of FDA data
Cardiogenic shock is found among people who take Gabapentin, especially for people who are male, 60+ old, have been taking the drug for 2 - 5 years.
The phase IV clinical study analyzes which people take Gabapentin and have Cardiogenic shock. It is created by eHealthMe based on reports of 264,649 people who have side effects when taking Gabapentin from the FDA, and is updated regularly. You can use the study as a second opinion to make health care decisions.
Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.
264,649 people reported to have side effects when taking Gabapentin.
Among them, 316 people (0.12%) have Cardiogenic shock.
What is Gabapentin?
Gabapentin has active ingredients of gabapentin. It is often used in neuralgia. eHealthMe is studying from 273,137 Gabapentin users for its effectiveness, alternative drugs and more.
What is Cardiogenic shock?
Cardiogenic shock (inadequate circulation of blood) is found to be associated with 1,669 drugs and 1,069 conditions by eHealthMe.
Number of Gabapentin and Cardiogenic shock reports submitted per year:
Time on Gabapentin when people have Cardiogenic shock *:
Gender of people who have Cardiogenic shock when taking Gabapentin*:
Age of people who have Cardiogenic shock when taking Gabapentin *:
Common drugs people take besides Gabapentin *:
Common side effects people have besides Cardiogenic shock *:
Common conditions people have *:
* Approximation only. Some reports may have incomplete information.
Do you take Gabapentin and have Cardiogenic shock?Check whether Cardiogenic shock is associated with a drug or a condition
How to use the study?
You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.
Related publications that referenced our studies
- de Landaluce, L. O., Carbonell, P., Asensio, C., Escoda, N., López, P., & Laporte, J. R. , "Gabapentin and Pregabalin and Risk of Atrial Fibrillation in the Elderly: A Population-Based Cohort Study in an Electronic Prescription Database", Drug safety, 2018 Jan .
- Scarff JR, "The Potential for Somnambulism Associated with Gabapentin", The Internet Journal of Psychiatry, 2014 Jan .
How severe was Cardiogenic shock and when was it recovered:
Expand to all the drugs that have ingredients of gabapentin:
Alternative drugs to, pros and cons of Gabapentin:
- Gabapentin (273,137 reports)
Common Gabapentin side effects:
Browse all side effects of Gabapentin:a b c d e f g h i j k l m n o p q r s t u v w x y z
Cardiogenic shock treatments and more:
- Cardiogenic shock (13,996 reports)
COVID vaccines that are related to Cardiogenic shock:
- Cardiogenic shock in Moderna COVID Vaccine
- Cardiogenic shock in Pfizer BioNTech Covid Vaccine
- Cardiogenic shock in Johnson and Johnson Covid Vaccine
Common drugs associated with Cardiogenic shock:
All the drugs that are associated with Cardiogenic shock:
- Cardiogenic shock (1,669 drugs)
Common conditions associated with Cardiogenic shock:
All the conditions that are associated with Cardiogenic shock:
- Cardiogenic shock (1,069 conditions)
How the study uses the data?
The study uses data from the FDA. It is based on gabapentin (the active ingredients of Gabapentin) and Gabapentin (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
Who is eHealthMe?
With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Glyburide and Impaired Driving Ability - 13 seconds ago
- Ventolin Hfa and Loss Of Consciousness - 16 seconds ago
- Armour Thyroid and Ranexa drug interaction - 25 seconds ago
- Cleocin T and Flatulence - 41 seconds ago
- Lotemax and Jaw Disorder - 45 seconds ago
- Tykerb and Breathing Difficulty - 46 seconds ago
- Xeljanz and Lip Haemorrhage - 48 seconds ago
- Plaquenil and Pleurisy - 50 seconds ago
- Nitrol and Zometa drug interaction - a minute ago
- Lopurin and Waterhouse-Friderichsen Syndrome - a minute ago